ArticleLife (Basel, Switzerland)2022

A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.

Yan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.